{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:06:11Z","timestamp":1783015571479,"version":"3.54.6"},"reference-count":50,"publisher":"American Society of Hematology","issue":"19","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,9]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Sterile alpha motif and histidine-aspartate (HD) domain\u2013containing protein 1 (SAMHD1) is a deoxynucleoside triphosphate triphosphohydrolase with ara-CTPase activity that confers cytarabine (ara-C) resistance in several hematological malignancies. Targeting SAMHD1\u2019s ara-CTPase activity has recently been demonstrated to enhance ara-C efficacy in acute myeloid leukemia. Here, we identify the transcription factor SRY-related HMG-box containing protein 11 (SOX11) as a novel direct binding partner and first known endogenous inhibitor of SAMHD1. SOX11 is aberrantly expressed not only in mantle cell lymphoma (MCL), but also in some Burkitt lymphomas. Coimmunoprecipitation of SOX11 followed by mass spectrometry in MCL cell lines identified SAMHD1 as the top SOX11 interaction partner, which was validated by proximity ligation assay. In\u00a0vitro, SAMHD1 bound to the HMG box of SOX11 with low-micromolar affinity. In situ crosslinking studies further indicated that SOX11-SAMHD1 binding resulted in a reduced tetramerization of SAMHD1. Functionally, expression of SOX11 inhibited SAMHD1 ara-CTPase activity in a dose-dependent manner resulting in ara-C sensitization in cell lines and in a SOX11-inducible mouse model of MCL. In SOX11-negative MCL, SOX11-mediated ara-CTPase inhibition could be mimicked by adding the recently identified SAMHD1 inhibitor hydroxyurea. Taken together, our results identify SOX11 as a novel SAMHD1 interaction partner and its first known endogenous inhibitor with potentially important implications for clinical therapy stratification.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2023022241","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T21:51:27Z","timestamp":1705614687000},"page":"1953-1964","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-795X","authenticated-orcid":false,"given":"Mohammad Hamdy","family":"Abdelrazak Morsy","sequence":"first","affiliation":[{"name":"1Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"},{"name":"2Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-7268","authenticated-orcid":false,"given":"Ingrid","family":"Lilienthal","sequence":"additional","affiliation":[{"name":"3Childhood Cancer Research Unit, Department of Women\u2019s, and Children\u2019s Health, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-3187","authenticated-orcid":false,"given":"Martin","family":"Lord","sequence":"additional","affiliation":[{"name":"4Department of Pharmaceutical Biosciences, Immuno-oncology, Uppsala University Biomedical Centre, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-6300","authenticated-orcid":false,"given":"Magali","family":"Merrien","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-3856","authenticated-orcid":false,"given":"Agata Magdalena","family":"Wasik","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-2673","authenticated-orcid":false,"given":"Marta","family":"Sureda-G\u00f3mez","sequence":"additional","affiliation":[{"name":"5Institut d'Investigacions Biom\u00e8diques August Pi Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-2874","authenticated-orcid":false,"given":"Virginia","family":"Amador","sequence":"additional","affiliation":[{"name":"5Institut d'Investigacions Biom\u00e8diques August Pi Sunyer, Barcelona, Spain"},{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-4205","authenticated-orcid":false,"given":"Henrik J.","family":"Johansson","sequence":"additional","affiliation":[{"name":"7Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-9562","authenticated-orcid":false,"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[{"name":"7Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3581-9337","authenticated-orcid":false,"given":"Beatriz","family":"Garcia-Torre","sequence":"additional","affiliation":[{"name":"5Institut d'Investigacions Biom\u00e8diques August Pi Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jose Ignacio","family":"Martin-Subero","sequence":"additional","affiliation":[{"name":"5Institut d'Investigacions Biom\u00e8diques August Pi Sunyer, Barcelona, Spain"},{"name":"8Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tsesmetzis","sequence":"additional","affiliation":[{"name":"3Childhood Cancer Research Unit, Department of Women\u2019s, and Children\u2019s Health, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Tao","sequence":"additional","affiliation":[{"name":"9Center for ViroScience and Cure, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-3614","authenticated-orcid":false,"given":"Raymond F.","family":"Schinazi","sequence":"additional","affiliation":[{"name":"9Center for ViroScience and Cure, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-4335","authenticated-orcid":false,"given":"Baek","family":"Kim","sequence":"additional","affiliation":[{"name":"9Center for ViroScience and Cure, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes L.","family":"Sorteberg","sequence":"additional","affiliation":[{"name":"3Childhood Cancer Research Unit, Department of Women\u2019s, and Children\u2019s Health, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Wickstr\u00f6m","sequence":"additional","affiliation":[{"name":"3Childhood Cancer Research Unit, Department of Women\u2019s, and Children\u2019s Health, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-4429","authenticated-orcid":false,"given":"Devon","family":"Sheppard","sequence":"additional","affiliation":[{"name":"10Macromolecular Structure Laboratory, The Francis Crick Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios Z.","family":"Rassidakis","sequence":"additional","affiliation":[{"name":"7Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden"},{"name":"11Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-3852","authenticated-orcid":false,"given":"Ian A.","family":"Taylor","sequence":"additional","affiliation":[{"name":"10Macromolecular Structure Laboratory, The Francis Crick Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Christensson","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"5Institut d'Investigacions Biom\u00e8diques August Pi Sunyer, Barcelona, Spain"},{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"12Hematopathology Section, Department of Anatomic Pathology, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-4543","authenticated-orcid":false,"given":"Nikolas","family":"Herold","sequence":"additional","affiliation":[{"name":"3Childhood Cancer Research Unit, Department of Women\u2019s, and Children\u2019s Health, Karolinska Institutet, Solna, Sweden"},{"name":"13Paediatric Oncology, Astrid Lindgren Children\u2019s Hospital, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-1340","authenticated-orcid":false,"given":"Birgitta","family":"Sander","sequence":"additional","affiliation":[{"name":"1Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"48","key":"2024050915204362000_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jncimonographs\/lgu005","article-title":"Rationale and design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"JNCI Monographs"},{"issue":"5","key":"2024050915204362000_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"34","author":"Navarro","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2024050915204362000_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.2021013326","article-title":"Therapeutic options for relapsed\/refractory mantle cell lymphoma","volume":"139","author":"Eyre","year":"2022","journal-title":"Blood"},{"issue":"13","key":"2024050915204362000_bib4","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.3390\/cancers14133229","article-title":"Tumor microenvironment and immunotherapy-based approaches in mantle cell lymphoma","volume":"14","author":"Saleh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10044","key":"2024050915204362000_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(16)00739-X","article-title":"Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network","volume":"388","author":"Hermine","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"2024050915204362000_bib6","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","article-title":"Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in\u00a0vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group","volume":"112","author":"Geisler","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2024050915204362000_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14241","article-title":"15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau","volume":"175","author":"Eskelund","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"2024050915204362000_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","article-title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","volume":"131","author":"Aukema","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2024050915204362000_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.22.01780","article-title":"High-dose cytarabine and autologous stem-cell transplantation in mantle cell lymphoma: long-term follow-up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network","volume":"41","author":"Hermine","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"2024050915204362000_bib10","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/bloodadvances.2023009744","article-title":"Long term follow-up of rituximab plus bendamustine and cytarabine (R-BAC) in elderly patients with newly diagnosed MCL","volume":"7","author":"Tisi","year":"2023","journal-title":"Blood Adv"},{"key":"2024050915204362000_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2017.05.001","article-title":"With me or against me: tumor suppressor and drug resistance activities of SAMHD1","volume":"52","author":"Herold","year":"2017","journal-title":"Exp Hematol"},{"issue":"7377","key":"2024050915204362000_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2024050915204362000_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1189\/jlb.4HI0714-338RR","article-title":"SAMHD1's protein expression profile in humans","volume":"98","author":"Schmidt","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"issue":"11","key":"2024050915204362000_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/15384101.2017.1314407","article-title":"SAMHD1 protects cancer cells from various nucleoside-based antimetabolites","volume":"16","author":"Herold","year":"2017","journal-title":"Cell Cycle"},{"issue":"11","key":"2024050915204362000_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-018-0134-z","article-title":"Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens","volume":"8","author":"Rassidakis","year":"2018","journal-title":"Blood Cancer J"},{"issue":"2","key":"2024050915204362000_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nm.4255","article-title":"SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia","volume":"23","author":"Schneider","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"2024050915204362000_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.4265","article-title":"Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies","volume":"23","author":"Herold","year":"2017","journal-title":"Nat Med"},{"issue":"1","key":"2024050915204362000_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ijc.33202","article-title":"The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: an analysis of the MCL Younger and Elderly trial","volume":"148","author":"Roider","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"2024050915204362000_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00428-021-03228-w","article-title":"Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma","volume":"480","author":"Merrien","year":"2022","journal-title":"Virchows Arch"},{"issue":"pt 1","key":"2024050915204362000_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","article-title":"The role of SOX family members in solid tumours and metastasis","volume":"67","author":"Grimm","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2024050915204362000_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2024050915204362000_bib22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"2024050915204362000_bib23","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"2024050915204362000_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjh.17874","article-title":"Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features","volume":"196","author":"Richter","year":"2022","journal-title":"Br J Haematol"},{"issue":"4","key":"2024050915204362000_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOH.0000000000000434","article-title":"SOX11, a key oncogenic factor in mantle cell lymphoma","volume":"25","author":"Beekman","year":"2018","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"2024050915204362000_bib26","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/eji.1830270534","article-title":"Sox-4 facilitates thymocyte differentiation","volume":"27","author":"Schilham","year":"1997","journal-title":"Eur J Immunol"},{"issue":"6576","key":"2024050915204362000_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/380711a0","article-title":"Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4","volume":"380","author":"Schilham","year":"1996","journal-title":"Nature"},{"issue":"22","key":"2024050915204362000_bib28","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood.2020010527","article-title":"SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma","volume":"138","author":"Balsas","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2024050915204362000_bib29","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","article-title":"SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma","volume":"121","author":"Vegliante","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2024050915204362000_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","article-title":"SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma","volume":"130","author":"Balsas","year":"2017","journal-title":"Blood"},{"issue":"14","key":"2024050915204362000_bib31","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","article-title":"SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma","volume":"124","author":"Palomero","year":"2014","journal-title":"Blood"},{"issue":"20","key":"2024050915204362000_bib32","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2018-02-832535","article-title":"SOX11 augments BCR signaling to drive MCL-like tumor development","volume":"131","author":"Kuo","year":"2018","journal-title":"Blood"},{"issue":"7","key":"2024050915204362000_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2217\/fon.15.18","article-title":"SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString)","volume":"11","author":"Walter","year":"2015","journal-title":"Future Oncol"},{"issue":"2","key":"2024050915204362000_bib34","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr3403","article-title":"Embryonic mammary signature subsets are activated in Brca1-\/- and basal-like breast cancers","volume":"15","author":"Zvelebil","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"pt 1","key":"2024050915204362000_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2020.06.015","article-title":"Regulatory roles for SOX11 in development, stem cells and cancer","volume":"67","author":"Tsang","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"2024050915204362000_bib36","doi-asserted-by":"crossref","first-page":"e10419","DOI":"10.15252\/emmm.201910419","article-title":"Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy","volume":"12","author":"Rudd","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"5","key":"2024050915204362000_bib37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/ac902737j","article-title":"Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry","volume":"82","author":"Fromentin","year":"2010","journal-title":"Anal Chem"},{"issue":"W1","key":"2024050915204362000_bib38","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2024050915204362000_bib39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1042\/BST20180348","article-title":"The missing link: allostery and catalysis in the anti-viral protein SAMHD1","volume":"47","author":"Morris","year":"2019","journal-title":"Biochem Soc Trans"},{"issue":"10","key":"2024050915204362000_bib40","doi-asserted-by":"crossref","first-page":"e1005194","DOI":"10.1371\/journal.ppat.1005194","article-title":"Phospho-dependent regulation of SAMHD1 oligomerisation couples catalysis and restriction","volume":"11","author":"Arnold","year":"2015","journal-title":"PLoS Pathog"},{"issue":"7","key":"2024050915204362000_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/cancers10070240","article-title":"Nucleobase and nucleoside analogues: resistance and re-sensitisation at the level of pharmacokinetics, pharmacodynamics and metabolism","volume":"10","author":"Tsesmetzis","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2024050915204362000_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/17460441.2020.1811672","article-title":"Pharmacological strategies to overcome treatment resistance in acute myeloid leukemia: increasing leukemic drug exposure by targeting the resistance factor\u00a0SAMHD1 and the toxicity factor Top2\u03b2","volume":"16","author":"Herold","year":"2021","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"2024050915204362000_bib43","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2024050915204362000_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-020-20849-y","article-title":"Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation","volume":"12","author":"Vilarrasa-Blasi","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"2024050915204362000_bib45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ajh.26523","article-title":"Mantle cell lymphoma in 2022-a comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments","volume":"97","author":"Jain","year":"2022","journal-title":"Am J Hematol"},{"issue":"2","key":"2024050915204362000_bib46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjh.17419","article-title":"Mantle cell lymphoma \u2013 advances in molecular biology, prognostication and treatment approaches","volume":"195","author":"Silkenstedt","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"2024050915204362000_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","article-title":"SOX11 and TP53 add prognostic information to MIPI\u00a0in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study","volume":"166","author":"Nordstr\u00f6m","year":"2014","journal-title":"Br J Haematol"},{"issue":"18","key":"2024050915204362000_bib48","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","article-title":"Prognostic role of SOX11 in a population-based cohort of mantle cell\u00a0lymphoma","volume":"119","author":"Nygren","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2024050915204362000_bib49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3324\/haematol.2019.219543","article-title":"Highly sensitive and specific in situ hybridization assay for quantification of SOX11 mRNA in mantle cell lymphoma reveals association of TP53 mutations with negative and low SOX11 expression","volume":"105","author":"Federmann","year":"2020","journal-title":"Haematologica"},{"key":"2024050915204362000_bib50","doi-asserted-by":"crossref","first-page":"106608","DOI":"10.1016\/j.leukres.2021.106608","article-title":"SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in\u00a0vitro resistance to nucleoside analogues","volume":"107","author":"B\u00fchler","year":"2021","journal-title":"Leuk Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/19\/1953\/2224784\/blood_bld-2023-022241-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/19\/1953\/2224784\/blood_bld-2023-022241-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T15:21:08Z","timestamp":1715268068000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/19\/1953\/514642\/SOX11-is-a-novel-binding-partner-and-endogenous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":50,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,5,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023022241","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}